HomeCompareRNAM vs O

RNAM vs O: Dividend Comparison 2026

RNAM yields 2.74% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 O wins by $10.4K in total portfolio value· pulled ahead in Year 5
10 years
RNAM
RNAM
● Live price
2.74%
Share price
$72.86
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.8K
Annual income
$327.66
Full RNAM calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — RNAM vs O

📍 O pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRNAMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RNAM + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RNAM pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNAM
Annual income on $10K today (after 15% tax)
$233.32/yr
After 10yr DRIP, annual income (after tax)
$278.51/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, O beats the other by $4,058.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNAM + O for your $10,000?

RNAM: 50%O: 50%
100% O50/50100% RNAM
Portfolio after 10yr
$29.0K
Annual income
$2,715.20/yr
Blended yield
9.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

RNAM
Analyst Ratings
2
Buy
9
Hold
Consensus: Hold
Altman Z
23.7
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNAM buys
0
O buys
0
No recent congressional trades found for RNAM or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRNAMO
Forward yield2.74%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$23.8K$34.2K
Annual income after 10y$327.66$5,102.74
Total dividends collected$3.0K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: RNAM vs O ($10,000, DRIP)

YearRNAM PortfolioRNAM Income/yrO PortfolioO Income/yrGap
1$10,974$274.50$10,818$608.16+$156.00RNAM
2$12,024$281.54$11,787$741.68+$237.00RNAM
3$13,154$288.29$12,946$911.00+$208.00RNAM
4$14,370$294.75$14,345$1,127.94+$25.00RNAM
5← crossover$15,677$300.92$16,056$1,409.05$379.00O
6$17,081$306.81$18,171$1,777.83$1.1KO
7$18,589$312.42$20,820$2,268.21$2.2KO
8$20,208$317.77$24,188$2,929.90$4.0KO
9$21,945$322.84$28,533$3,837.11$6.6KO
10$23,809$327.66$34,235$5,102.74$10.4KO

RNAM vs O: Complete Analysis 2026

RNAMStock

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Full RNAM Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this RNAM vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNAM vs SCHDRNAM vs JEPIRNAM vs KORNAM vs MAINRNAM vs STAGRNAM vs ADCRNAM vs NNNRNAM vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.